{
  "meta": {
    "data_length": 1,
    "message": "Therapy group id txgrp:145 retrieved successfully",
    "request_url": "https://api.moalmanac.org/therapy_groups?therapy_group_id=txgrp%3A145",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001896,
    "timestamp_received": "2026-10-16T23:37:32.833588+00:00Z",
    "timestamp_returned": "2026-10-16T23:37:32.835484+00:00Z",
    "trace_id": "bc2ca626-6833-4d60-b38b-368904f44222"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "txgrp:145",
      "membershipOperator": "AND",
      "therapies": [
        {
          "id": "tx:ncit:C78825",
          "conceptType": "Therapy",
          "name": "Idelalisib",
          "mappings": [
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:rxcui:1544460",
                "code": "1544460",
                "name": "idelalisib",
                "system": "RxNorm",
                "systemVersion": "02-Mar-2026",
                "iris": [
                  "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1544460"
                ]
              }
            },
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:omop:45776944",
                "code": "45776944",
                "name": "idelalisib",
                "system": "OMOP",
                "systemVersion": "v20260227",
                "iris": [
                  "https://athena.ohdsi.org/search-terms/terms/45776944"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "therapy_strategy",
              "value": [
                "PI3K/AKT/mTOR inhibition"
              ],
              "description": "Associated therapeutic strategy or mechanism of action of the therapy."
            },
            {
              "name": "therapy_type",
              "value": "Targeted therapy",
              "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C78825",
            "code": "C78825",
            "name": "Idelalisib",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C78825"
            ]
          }
        },
        {
          "id": "tx:ncit:C1702",
          "conceptType": "Therapy",
          "name": "Rituximab",
          "mappings": [
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:rxcui:121191",
                "code": "121191",
                "name": "rituximab",
                "system": "RxNorm",
                "systemVersion": "02-Mar-2026",
                "iris": [
                  "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=121191"
                ]
              }
            },
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:omop:1314273",
                "code": "1314273",
                "name": "rituximab",
                "system": "OMOP",
                "systemVersion": "v20260227",
                "iris": [
                  "https://athena.ohdsi.org/search-terms/terms/1314273"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "therapy_strategy",
              "value": [
                "CD20 inhibition"
              ],
              "description": "Associated therapeutic strategy or mechanism of action of the therapy."
            },
            {
              "name": "therapy_type",
              "value": "Immunotherapy",
              "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C1702",
            "code": "C1702",
            "name": "Rituximab",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C1702"
            ]
          }
        }
      ]
    }
  ]
}